cd 437 has been researched along with Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhuiyan, M; Chao, WR; Dawson, MI; Farhana, L; Feng, GS; Fontana, JA; Han, YH; Hobbs, PD; Jiang, T; Jong, L; Macchiarulo, A; Nuti, R; Pang, Y; Patel, B; Pellicciari, R; Su, Y; Tautz, L; Waleh, N; Xia, Z; Xue, LP; Ye, M; Zhang, XK | 1 |
| Aladjem, MI; Ceribelli, M; Fu, H; Jo, U; Murai, J; Murai, Y; Pommier, Y; Redon, CE; Thomas, CJ | 1 |
| Akechi, Y; Hashiguchi, K; Kurimasa, A; Nozaki, M; Sakabe, T; Shiota, G; Tomita, A; Tsuchida, S; Tsuchiya, H; Ueda, C; Yamada, T | 1 |
| Zhang, XK | 1 |
| Fontana, JA; Rishi, AK | 1 |
2 review(s) available for cd 437 and Neoplasms
| Article | Year |
|---|---|
Targeting Nur77 translocation.
Topics: Animals; Apoptosis; Cell Nucleus; Cell Survival; DNA-Binding Proteins; Humans; Mitochondria; Neoplasms; Nuclear Receptor Subfamily 4, Group A, Member 1; Protein Transport; Proto-Oncogene Proteins c-bcl-2; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Retinoid X Receptors; Retinoids; Transcription Factors | 2007 |
Classical and novel retinoids: their targets in cancer therapy.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents; Fenretinide; Humans; Neoplasms; Receptors, Retinoic Acid; Retinoids | 2002 |
3 other study(ies) available for cd 437 and Neoplasms
| Article | Year |
|---|---|
Adamantyl-substituted retinoid-derived molecules that interact with the orphan nuclear receptor small heterodimer partner: effects of replacing the 1-adamantyl or hydroxyl group on inhibition of cancer cell growth, induction of cancer cell apoptosis, and
Topics: Adamantane; Antineoplastic Agents; Apoptosis; Cell Division; Cell Line, Tumor; Cinnamates; Dimerization; Enzyme Inhibitors; Humans; Models, Molecular; Neoplasms; Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 2008 |
Schlafen 11 (SLFN11) Kills Cancer Cells Undergoing Unscheduled Re-replication.
Topics: Antineoplastic Agents; Cell Line, Tumor; Chromatin; Cyclopentanes; Humans; Neoplasms; Nuclear Proteins | 2023 |
Involvement of ETS1 in thioredoxin-binding protein 2 transcription induced by a synthetic retinoid CD437 in human osteosarcoma cells.
Topics: Antineoplastic Agents; Apoptosis; Carrier Proteins; Cell Line, Tumor; Chromatin Immunoprecipitation; Humans; Neoplasms; Promoter Regions, Genetic; Proto-Oncogene Protein c-ets-1; Retinoids; Transcription, Genetic | 2010 |